Mark Heinen - Dec 13, 2021 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Head of Finance and interim Chief Financial Officer
Signature
/s/ Mark Heinen
Stock symbol
BTTX
Transactions as of
Dec 13, 2021
Transactions value $
$16,400
Form type
4
Date filed
12/15/2021, 03:53 PM
Previous filing
Nov 1, 2021
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $2.73K +500 +7.5% $5.45* 7.17K Dec 13, 2021 Direct F1
transaction BTTX Common Stock Purchase $2.72K +500 +6.98% $5.44* 7.67K Dec 14, 2021 Direct
transaction BTTX Common Stock Purchase $11K +2.33K +30.43% $4.70* 10K Dec 15, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the correction of an immaterial error in Column 5 reported in the Reporting Person's Form 4 filed on November 1, 2021.

Remarks:

Head of Finance and interim Chief Financial Officer